DoubleLine ETF Adviser’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$671K Sell
15,313
-3,737
-20% -$171K 0.26% 97
2025
Q4
$845K Buy
19,050
+1,008
+6% +$43.4K 0.25% 97
2025
Q3
$762K Buy
18,042
+955
+6% +$38.5K 0.23% 107
2025
Q2
$626K Buy
17,087
+1,391
+9% +$51.6K 0.2% 110
2025
Q1
$598K Sell
15,696
-2,821
-15% -$105K 0.2% 114
2024
Q4
$701K Buy
18,517
+121
+0.7% +$4.83K 0.19% 117
2024
Q3
$749K Buy
+18,396
New +$696K 0.18% 127
2024
Q2
Sell
-18,509
Closed -$586K 224
2024
Q1
$586K Buy
18,509
+1,651
+10% +$50.2K 0.15% 139
2023
Q4
$517K Buy
+16,858
New +$541K 0.15% 134
2023
Q2
Sell
-11,816
Closed -$324K 227
2023
Q1
$324K Buy
11,816
+1,444
+14% +$40.2K 0.14% 146
2022
Q4
$290K Buy
+10,372
New +$313K 0.15% 147

Other funds holding OHI

DoubleLine ETF Adviser's OHI Position: Q1 2026 in Review

DoubleLine ETF Adviser reduced its Omega Healthcare (OHI) stake by 20% in Q1 2026, selling an estimated $171K and leaving 15,313 shares worth $671K. The position accounts for 0.26% of the portfolio, ranked #97.

DoubleLine ETF Adviser first reported a position in OHI in Q4 2022 and has held it in 11 quarters since. The position peaked at $845K in Q4 2025. 741 funds tracked by Wall St. Rank hold OHI as of Q1 2026.

  • DoubleLine ETF Adviser held 15,313 shares of Omega Healthcare worth $671K as of Q1 2026.
  • DoubleLine ETF Adviser sold 3,737 Omega Healthcare shares in Q1 2026, an estimated $171K.
  • Omega Healthcare made up 0.26% of DoubleLine ETF Adviser's portfolio in Q1 2026, its #97 holding.
  • DoubleLine ETF Adviser first reported a position in Omega Healthcare in Q4 2022 and has held it in 11 quarters since.
  • DoubleLine ETF Adviser's Omega Healthcare position peaked at $845K in Q4 2025.
  • 741 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2026.

Based on DoubleLine ETF Adviser's 13F filing for Q1 2026, filed 15 May 2026.